Antimicrobial resistance and prudent drug use for Streptococcus suis.
about
Capsular serotypes, virulence-associated genes and antimicrobial susceptibility of Streptococcus suis isolates from pigs in KoreaSuicin 90-1330 from a nonvirulent strain of Streptococcus suis: a nisin-related lantibiotic active on gram-positive swine pathogens.Characterization of the pivotal carbon metabolism of Streptococcus suis serotype 2 under ex vivo and chemically defined in vitro conditions by isotopologue profiling.Characterization of multi-drug tolerant persister cells in Streptococcus suis.Suicin 3908, a new lantibiotic produced by a strain of Streptococcus suis serotype 2 isolated from a healthy carrier pig.Isolation, Characterization and Biological Properties of Membrane Vesicles Produced by the Swine Pathogen Streptococcus suis.Purification and Characterization of Suicin 65, a Novel Class I Type B Lantibiotic Produced by Streptococcus suisThe Phage Lysin PlySs2 Decolonizes Streptococcus suis from Murine Intranasal Mucosa.In Vivo Pharmacodynamics of Cefquinome in a Neutropenic Mouse Thigh Model of Streptococcus suis Serotype 2 at Varied Initial Inoculum Sizes.FlpS, the FNR-Like Protein of Streptococcus suis Is an Essential, Oxygen-Sensing Activator of the Arginine Deiminase SystemIn vitro and in vivo antibacterial effect of NZ2114 against Streptococcus suis type 2 infection in mice peritonitis models.Comparative Transcriptomic Analysis of Porcine Peripheral Blood Reveals Differentially Expressed Genes from the Cytokine-cytokine Receptor Interaction Pathway Related to Health Status.Human case of bacteremia due to Streptococcus suis serotype 5 in Japan: The first report and literature review.Use of Antibiotics and Antimicrobial Resistance in Veterinary Medicine as Exemplified by the Swine Pathogen Streptococcus suis.Patterns of antimicrobial resistance in Streptococcus suis isolates from pigs with or without streptococcal disease in England between 2009 and 2014.A novel prophage lysin Ply5218 with extended lytic activity and stability against Streptococcus suis infection.Streptococcus suis in employees and the environment of swine slaughterhouses in São Paulo, Brazil: Occurrence, risk factors, serotype distribution, and antimicrobial susceptibility.Production of anti-streptococcal liamocins from agricultural biomass by Aureobasidium pullulans.Polyols, not sugars, determine the structural diversity of anti-streptococcal liamocins produced by Aureobasidium pullulans strain NRRL 50380.EMA and EFSA Joint Scientific Opinion on measures to reduce the need to use antimicrobial agents in animal husbandry in the European Union, and the resulting impacts on food safety (RONAFA)PK-PD Analysis of Marbofloxacin against Streptococcus suis in Pigs.PK-PD Integration Modeling and Cutoff Value of Florfenicol against Streptococcus suis in Pigs.Effect of Early-Life Treatment of Piglets with Long-Acting Ceftiofur on Colonization of Streptococcus suis Serotype 7 and Elicitation of Specific Humoral Immunity in a Farm Dealing with Streptococcal Diseases.Combination Therapy Strategies Against Multiple-Resistant Streptococcus Suis.
P2860
Q33594030-E739CF1C-F7AA-4809-8281-ACF2A8523D66Q34058400-4C01A403-F72B-497A-8414-672A2A37F8DBQ35126711-0A83AA99-8302-49D2-B5CB-474A47C586CBQ35178525-30928385-CD31-476D-B992-AB351FAD3BDCQ35557199-608DB8B5-5966-46F5-B162-302173DB6AACQ35673986-144D53E7-7B01-4314-8C71-B3662779FF75Q35879452-42342781-5220-4332-A890-B5B3D8AB32A2Q36238470-7622D368-C2E4-4BB3-B201-78E986850147Q36571798-A5FF1CC2-814B-40C9-9B97-4703DE4EB27FQ37290697-7CC152F7-159B-49DB-BA97-F31B9488CAAFQ37653394-984CA133-D235-4E53-885F-5E6074B2B947Q38430487-1B45C1F6-6BCA-4A6D-B90D-149BB62E232EQ38968752-C00084A5-A9DE-4820-A0D6-C27A73EA234CQ38980023-984BF255-E45E-4047-B288-CE2E009361C5Q39065080-65645C4F-8792-4DC7-9EDD-BA8AEF8F3D6AQ39535283-FDB0A57B-C94A-412E-8ADE-FD5603DF0A95Q40971618-361C91FC-CE57-4E59-A372-791764A0B385Q46475476-4B763B37-4DE4-4347-B0B4-B96819DE1D0DQ46513917-5073E42B-AC0D-401C-BDC5-1B18D1CF4E58Q47158624-81BEBE5C-DF0F-4595-A51F-4D374302C811Q47362352-021A2AEE-54D9-4EF5-8840-343B01A9EAA8Q47701094-56153E6E-6145-4C38-8D71-67DB285E5CACQ53700364-046F9910-4680-40F4-B98A-294E8974156EQ54968871-F8188976-3DAF-418B-9807-FBBCB36884F9
P2860
Antimicrobial resistance and prudent drug use for Streptococcus suis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antimicrobial resistance and prudent drug use for Streptococcus suis.
@en
type
label
Antimicrobial resistance and prudent drug use for Streptococcus suis.
@en
prefLabel
Antimicrobial resistance and prudent drug use for Streptococcus suis.
@en
P2093
P2860
P1476
Antimicrobial resistance and prudent drug use for Streptococcus suis.
@en
P2093
Claude Thibault
Jeff Wilson
Norma P Varela
Pierre Gadbois
P2860
P356
10.1017/S1466252313000029
P577
2013-05-20T00:00:00Z